Lys Therapeutics
PrivateLast Round
VC Round
Jun 22, 2026
Total Funding Raised
$15.85M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Lys Therapeutics is a biotechnology company developing first-in-class monoclonal antibodies to treat patients with severe neurodegenerative and neurovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lys Therapeutics Comparables
Compare Lys Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuvasq Biotechnologies | 81% | |
| Axoltis Pharma | 80% | |
| Phragma Therapeutics | 79% | |
Lys Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 22, 2026 | ||||
| Grant | Sep 22, 2025 | ||||
| Grant | Sep 24, 2024 | ||||
| Grant | Nov 14, 2023 | ||||
| Seed | Nov 14, 2022 | ||||
Grant | Oct 15, 2021 |
Key People
Founding team and executive leadership
Lys Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant, VC Round |
| Ministry of Higher Education and Research | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant, VC Round |
| Normandie Participations | VC Round |
| Bpifrance | Grant, Seed, VC Round |
| Zcube | Seed, VC Round |
| TCD Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 101% MoM.
- Jun 22, 2026
$29M raised with participation from Bpifrance and France 2030.
Lys Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lys Therapeutics's valuation, stock price, and market status.